Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Namita Padwal

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Cancer Research and Therapeutics|April 11, 2025
Myelomatous pleural effusion: An atypical initial presentationSimran J Thakkar, Namita Padwal, Niteen Karnik
The Journal of the Association of Physicians of India|October 24, 2018
Mortality in Malaria: Intensive Care (MIMIC)Trupti Trivedi, Poonam Bajaj, Nivedita Moulick, et al.
Journal of Cancer Research and Therapeutics|October 16, 2024
Idiopathic multicentric Castleman diseaseVipul Chaudhari, Simran Jatin Thakkar, Namita Padwal, et al.
The Journal of the Association of Physicians of India|May 8, 2024
A Case of Refractory Anemia in Patient of Chronic Kidney Disease and the Challenges in its ManagementKomal Gade, Charulata Londhe, Sangeeta Pednekar, et al.
The Journal of the Association of Physicians of India|September 2, 2021
COVID-19 Associated Stroke-A Single Centre ExperienceUma Sundar, Niteen D Karnik, Amita Mukhopadhyay, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 12, 2023
Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune ThrombocytopeniaS Chandrakala, Manoj Toshniwal, Mitesh Halvawala, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 12, 2023
Correction to: Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune ThrombocytopeniaS Chandrakala, Manoj Toshniwal, Mitesh Halvawala, et al.
BMC Infectious Diseases|March 6, 2021
Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, IndiaYojana Gokhale, Rakshita Mehta, Uday Kulkarni, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Cancer Research and Therapeutics|April 11, 2025
Myelomatous pleural effusion: An atypical initial presentationSimran J Thakkar, Namita Padwal, Niteen Karnik
The Journal of the Association of Physicians of India|October 24, 2018
Mortality in Malaria: Intensive Care (MIMIC)Trupti Trivedi, Poonam Bajaj, Nivedita Moulick, et al.
Journal of Cancer Research and Therapeutics|October 16, 2024
Idiopathic multicentric Castleman diseaseVipul Chaudhari, Simran Jatin Thakkar, Namita Padwal, et al.
The Journal of the Association of Physicians of India|May 8, 2024
A Case of Refractory Anemia in Patient of Chronic Kidney Disease and the Challenges in its ManagementKomal Gade, Charulata Londhe, Sangeeta Pednekar, et al.
The Journal of the Association of Physicians of India|September 2, 2021
COVID-19 Associated Stroke-A Single Centre ExperienceUma Sundar, Niteen D Karnik, Amita Mukhopadhyay, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 12, 2023
Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune ThrombocytopeniaS Chandrakala, Manoj Toshniwal, Mitesh Halvawala, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 12, 2023
Correction to: Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune ThrombocytopeniaS Chandrakala, Manoj Toshniwal, Mitesh Halvawala, et al.
BMC Infectious Diseases|March 6, 2021
Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, IndiaYojana Gokhale, Rakshita Mehta, Uday Kulkarni, et al.
Pageof 1